155 related articles for article (PubMed ID: 6122514)
1. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
[TBL] [Abstract][Full Text] [Related]
3. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
Simon G; Franciosa JA; Gimenez HJ; Cohn JN
Hypertension; 1981; 3(2):262-8. PubMed ID: 6111532
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
[TBL] [Abstract][Full Text] [Related]
5. Long-term renal hemodynamic effects of nadolol in patients with essential hypertension.
Frohlich ED; Messerli FH; Deslinski GR; Kobrin I
Am Heart J; 1984 Oct; 108(4 Pt 2):1141-3. PubMed ID: 6148875
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of celiprolol in essential hypertension.
Frohlich ED; Ketelhut R; Kaesser UR; Losem CJ; Messerli FH
Am J Cardiol; 1991 Aug; 68(5):509-14. PubMed ID: 1678580
[TBL] [Abstract][Full Text] [Related]
7. Bisoprolol and atenolol in essential hypertension: effects on systemic and renal hemodynamics and on ambulatory blood pressure.
Leeman M; van de Borne P; Collart F; Vandenhoven G; Peeters L; Mélot C; Degaute JP
J Cardiovasc Pharmacol; 1993 Dec; 22(6):785-91. PubMed ID: 7509894
[TBL] [Abstract][Full Text] [Related]
8. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
9. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
Branten AJ; Hilbrands LB; van Hamersvelt HW; Koene RA; Huysmans FT
Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456
[TBL] [Abstract][Full Text] [Related]
10. Effects of carvedilol on renal function.
Dupont AG
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S96-100. PubMed ID: 1974513
[TBL] [Abstract][Full Text] [Related]
11. Acute effect of atenolol on hemodynamic, plasma renin activity and plasma aldosterone concentration in the once daily oral administration.
Sasaki Y; Arakawa K
Jpn Circ J; 1984 Sep; 48(9):988-93. PubMed ID: 6384568
[TBL] [Abstract][Full Text] [Related]
12. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives.
Brater DC; Anderson S; Kaplan NM; Ram CV
J Hypertens; 1984 Feb; 2(1):43-8. PubMed ID: 6152277
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
Ruilope LM
Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
[TBL] [Abstract][Full Text] [Related]
15. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
Saner H; Seiler A; Mahler F
Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of antihypertensive effect of atenolol in patients with borderline hypertension during short-term treatment. A comprehensive study.
Imai Y; Abe K; Sato M; Kasai Y; Sato K; Omata K; Sasaki S; Nihei M; Sekino H; Yoshinaga K
Arzneimittelforschung; 1986 May; 36(5):869-73. PubMed ID: 3730023
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
18. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications.
Zusman RM; Christensen DM; Higgins J; Boucher CA
J Cardiovasc Pharmacol; 1992 Aug; 20(2):216-22. PubMed ID: 1381012
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).
Meekers J; Missotten A; Fagard R; Demuynck D; Harvengt C; Pas P; Billiet L; Amery A
Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
